Abstract
OBJECTIVES: To describe and explain the patterns of adherence to supplemental oxygen in individuals with hypoxemic chronic obstructive pulmonary disease (COPD).
DESIGN: Qualitative study of a case-series of patients with COPD who use supplemental oxygen.
SETTING: Denver, Colorado.
PARTICIPANTS: Community-dwelling, English speaking individuals with hypoxemic COPD receiving long-term supplemental oxygen therapy.
MEASUREMENTS: Forced expiratory lung volume, in liters, at one second (FEV1), the St. George’s Respiratory Questionnaire, Brief Symptom Inventory, semistructured investigator-administered interviews.
RESULTS: Respondents from a demographically representative sample with moderate to severe COPD (average age, 69; average FEV1, 1.1) described 3 distinct patterns of adherence to supplemental oxygen therapy: as-needed use, part-time use, and full-time use. For many individuals, the pattern of adherence changed with time and reflected their struggle to optimally manage their health, symptoms, physical function, and social milieu. Adherence to oxygen tended to increase with time and was often associated with significant personal compromises.
CONCLUSION: Adhering to oxygen therapy is a complex and difficult task with many barriers, including the physical difficulty of using the oxygen, self-consciousness and a sense of social stigma, lack of perceived benefit, and fear of deleterious side effects from treatment. Improving adherence may involve understanding the process of adapting to oxygen use and addressing the many barriers to therapy.
Similar content being viewed by others
References
Nocturnal Oxygen Therapy Trial. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med. 1980;93:391–8.
Block AJ, Castle JF, Keitt AS. Chronic oxygen therapy treatment of chronic obstructive pulmonary disease at sea level. Chest. 1974;65:279–88.
Leggett RJE, Flenley DC. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pumonale. BMJ. 1977;2:84–6.
Stewart BN, Hood CI, Block AJ. Long-term results of continuous oxygen therapy at sea-level. Chest. 1975;68:486–96.
Vergeret J, Brambilla C, Mounier L. Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy. Eur Respir J. 1989;2:20–5.
Levine BE, Bigelow DB, Hamstra RD, et al. The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia. Ann Intern Med. 1967;66:503–12.
Brezinova V, Claverly PMA, Flenley DC. The effect of long-term oxygen therapy on the EEG in patients with chronic airway obstruction with hypoxemia. Bull Eur Physiopathol Respir. 1979;15:603–9.
Krop HD, Block AJ, Cohn E. Neuropsychiatric effects of continuous oxygen therapy in chronic obstructive pulmonary disease. Chest. 1973;64:317–32.
McSweeney AJ, Grant I, Heaton RK. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med. 1982;142:473–8.
Walshaw MJ, Lim R, Evans CC. Factors influencing the compliance of patients using oxygen concentrators for long-term home oxygen therapy. Respir Med. 1990;84:331–3.
Phillips GD, Harrison NK, Cummin ARC. A new method for measuring compliance with long-term oxygen treatment. BMJ. 1994;308:1554–5.
Burns BH, Howell JBL. Disproportionately severe breathlessness in chronic bronchitis. Q J Med. 1969;38:277–94.
Heimlich HJ. Oxygen delivery for ambulatory patients: how the micro-trach increases mobility. Postgrad Med. 1988;84:68–79.
Hoffman LA, Dauber JH, Ferson PF. Patient response to transtracheal oxygen delivery. Am Rev Respir Dis. 1987;136:153–6.
Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13:595–605.
Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–7.
Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George’s Respiratory Questionnaire. [abstract]. Clin Ther. 2000;22:1121–45.
Ferrar M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med. 1997;127:1072–9.
Martin RJ, Pak J, Kunselman SJ, Cherniak RM. Assessment of the AirWatch lung function monitoring system. J Allergy Clin Immunol. 1999;103:535–6.
Giacomini MK, Cook DJ. Qualitative research in health care—are the results of the study valid. JAMA. 2000;284:357–62.
Steiner JF, Earnest MA. The language of medication taking. Ann Intern Med. 2000;132:926–30.
Author information
Authors and Affiliations
Corresponding author
Additional information
Received from the University of Colorado Health Sciences Center, Denver, Colo.
This work was supported by a grant from the Division of General Internal Medicine, University of Colorado Health Sciences Center, Denver, Colo.
Rights and permissions
About this article
Cite this article
Earnest, M.A. Explaining adherence to supplemental oxygen therapy. J GEN INTERN MED 17, 749–755 (2002). https://doi.org/10.1046/j.1525-1497.2002.20218.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2002.20218.x